ALPINE IMMUNE SCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum

ALPINE IMMUNE SCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum

ALPINE IMMUNE SCIENCES, INC. reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum of 81.00% for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-20.

Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum · last filed 2024-03-20

• ALPINE IMMUNE SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2023 was 81.00%, a 1.25% increase from fiscal 2022.
• ALPINE IMMUNE SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2022 was 80.00%, a 1.27% increase from fiscal 2021.
• ALPINE IMMUNE SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2021 was 79.00%, a 8.22% increase from fiscal 2020.
• ALPINE IMMUNE SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2020 was 73.00%, a 4.29% increase from fiscal 2019.